Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Preoperative Considerations for Patients Opting for Spinal Disc Replacement

    March 4, 2025

    How to Combat Winter Dryness & Dullness for Body Skin

    February 27, 2025

    Healthy Ways to Deal with Tobacco Addiction

    February 19, 2025
    Facebook X (Twitter) Instagram
    • Home
    • Blog
    • Privacy Policy
    • Contact Us
    • Get In Touch
    • Our Authors
    Facebook X (Twitter) Instagram
    7Medios7Medios
    • Addiction
    • Daily News
    • Dentistry
    • Mental Health
    • Nutrition
    • Personal Health
    7Medios7Medios
    Home » Blog » Chimeric Antibody Against HER2: An Overview
    Daily News

    Chimeric Antibody Against HER2: An Overview

    adminBy adminNovember 11, 2022Updated:May 25, 2024No Comments3 Mins Read4 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Chimeric Antibody
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Immunotherapy with anti-HER2 antibodies has been emerging to be promising for patients with HER2-positive breast cancer. With the recent reports of characterization with mouse monoclonal antibody that has been against HER2, they bind to the epitope different from the trastuzumab recognition and specifically plays a role in inhibiting the proliferation of tumor cells overexpressing HER2. 

    HER2 – A Overview

    The HER2 proto-oncogene encodes the receptor tyrosine kinase that is overexpressed in a varied number of solid tumors. The amplification of the gene has led to correlate the poor prognosis in patients with breast cancer. Immunotherapy with HER2 antibody has shown potential results in patients with positive breast cancer HER2. The HER2, aka ErbB2, is located on chromosome 17 and encodes about 135kDa transmembrane glycoprotein. 

    HER2 is the reason for breast cancer in 30% of women, associated with protein expression and poor prognosis. The HER2 has been accessible and suitable as a target for cancer immunotherapy with its oncogenic potential by the use of monoclonal antibodies. Trastuzumab is the very first humanized monoclonal antibody approved for therapeutic use in breast cancer patients with overexpression HER2.

    Discussion on Chimeric Antibody Against HER2

    Monoclonal antibodies are an important part of biological drug discovery and represent the progressing pharmaceutical industry. About 26 monoclonal antibodies are existent in the industry with FDA approval and over 200 are constructed that are yet to be approved. With the early success of the mouse monoclonal antibodies that are developing their place in the therapeutic applications. 

    With the unique approach of Chimeric Antibody, the process of chimerization has the potential reducing the immunogenicity of the mouse monoclonal antibody applied for human treatment. HER2 gene overexpression has been noted for certain number of human malignancies, and have been proven as a important therapeutic target.  Visit our partners,shoes – leaders in fashionable footwear!

    The mouse mAbs when chimerized and turning humanized, they are designed to be trastuzumab and pertuzumab. With trastuzumab being humanized mAb, it binds to the extracellular domain IV, HER2, thus inducing downregulation. For patients with metastatic breast cancer patients, the ones who respond to trastuzumab begin to demonstrate disease progression about a year from start. 

    New monoclonal antibodies generated with target specificity are novel to the extracellular domain of HER2. Pertuzumab is a combination therapy that is added with trastuzumab. The pertuzumab, another humanized monoclonal antibody, that binds to domain II of the HER2.

    The purified chimeric antibody has the potential to specifically bind to HER2 positive brest cancer tumor cells. The binding of the chimeric antibody to the tumor specific cell inhibits the further proliferation of them. Thus, chimeric antibody or anti-HER2 monoclonal antibody is proven valuable for targeted immunotherapy for HER2 positive malignant cells.

    GeNext Genomics have skilled professionals and expert scientists at work, who have standard procedures in check for producing monoclonal antibodies India. We have our own range of recombinant protein services that has high-quality products developed. GeNext Genomics takes pride in developing highly specific hyper immune library which serves the research and development sector. 

    chimeric antibody Hyper Immune Library monoclonal antibodies India recombinant protein
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleTop Reasons to Become a Medical Coder/Biller
    Next Article Things to Know Before Opting For Orbera Balloon Surgery
    admin

    Related Posts

    Easy Ways to Manage Stress during IVF

    January 11, 2025

    Dealing with Breast Cancer

    January 2, 2025

    Best Bodybuilding Tips to Help You Get Faster Results

    December 18, 2024
    Leave A Reply Cancel Reply

    Latest Posts

    Preoperative Considerations for Patients Opting for Spinal Disc Replacement

    March 4, 20253 Views

    How to Combat Winter Dryness & Dullness for Body Skin

    February 27, 20253 Views

    Healthy Ways to Deal with Tobacco Addiction

    February 19, 20254 Views

    4 Popular Rhinoplasty Procedures Surgeons Choose Today for Improving the Look of Your Nose

    February 3, 20252 Views
    Archives
    Categories
    • Addiction (4)
    • Cancer (1)
    • Daily News (17)
    • Dentistry (5)
    • Fitness (2)
    • Food (2)
    • Health Tips (5)
    • Hospitals & Clinics (1)
    • Nutrition (1)
    • Personal Health (12)
    • Surgery (8)
    • Therapy (2)
    • Treatment (4)
    • Weight Loss (3)
    Don't Miss

    Can we exercise after a lipoma removal?

    By adminFebruary 26, 2021

    The fatty tumors which normally fall under the skin are lipomas. Many lipomas can bring…

    A STEP-BY-STEP PROCESS OF A TOTAL SHOULDER REPLACEMENT SURGERY

    August 3, 2022

    Pressure Readings Demystified: How To Read Your Blood Pressure

    February 15, 2024
    About Us
    About Us

    Your source for the lifestyle news. This demo is crafted specifically to exhibit the use of the theme as a lifestyle site. Visit our main page for more demos.

    We're accepting new partnerships right now.

    Email Us: itsmesonu@gmail.com
    Contact: +91-9910-861-217

    Facebook X (Twitter) Pinterest YouTube WhatsApp
    Our Picks

    Preoperative Considerations for Patients Opting for Spinal Disc Replacement

    March 4, 2025

    How to Combat Winter Dryness & Dullness for Body Skin

    February 27, 2025

    Healthy Ways to Deal with Tobacco Addiction

    February 19, 2025
    Most Popular

    Can we exercise after a lipoma removal?

    February 26, 202141 Views

    A STEP-BY-STEP PROCESS OF A TOTAL SHOULDER REPLACEMENT SURGERY

    August 3, 202235 Views

    Pressure Readings Demystified: How To Read Your Blood Pressure

    February 15, 202415 Views
    © 2025 ThemeSphere. Designed by ThemeSphere.
    • Home
    • Blog
    • Privacy Policy
    • Contact Us
    • Get In Touch
    • Our Authors

    Type above and press Enter to search. Press Esc to cancel.